Latest News about AZN
Recent news which mentions AZN
   Regeneron Advances In Rare Disease Race With Positive Autoimmune Muscle Disorder Trial Data
   
  
  
  August 26, 2025
  From Benzinga
 
   BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up
   
  
  
  August 25, 2025
  From Benzinga
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  August 22, 2025
  From Benzinga
 
   UK Drug Pricing Talks Collapse, Drugmakers Reject Offer Citing 'Uncompetitive' System
   
  
  
  August 22, 2025
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts
   
  
  
  August 11, 2025
  From Benzinga
 
   Understanding Top International ETF TOUS in Three Stocks
   
  
  
  August 06, 2025
  From ETF Trends
 
   1 Small-Cap Biotech Stock Poised for a Breakout
   
  
  
  August 06, 2025
  From Motley Fool
 
   EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data
   
  
  
  August 05, 2025
  From Benzinga
 
   Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
   
  
  
  August 01, 2025
  From Benzinga
 
   AstraZeneca Q2 Sales Beat Estimates On Strong Cancer Drugs Revenues, Reaffirms 2025 Outlook
   
  
  
  July 29, 2025
  From Benzinga
 
   Earnings Scheduled For July 29, 2025
   
  
  
  July 29, 2025
  From Benzinga
 
   Why Is Micro-Cap AIM ImmunoTech Stock Surging?
   
  
  
  July 28, 2025
  From Benzinga
 
   5 Dividend Stocks to Hold for the Next 20 Years
   
  
  
  July 25, 2025
  From Motley Fool
 
   AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate
   
  
  
  July 24, 2025
  From Benzinga
 From Benzinga
 From Benzinga
 
   AstraZeneca's Multi-Billion Dollar Cancer Drug Tagrisso Improves Overall Survival In Patients With Advanced Lung Cancer
   
  
  
  July 21, 2025
  From Benzinga
 From Benzinga
 
   AstraZeneca's Experimental Therapy Stumbles In Late-Stage Study For Rare Protein Deposit Condition
   
  
  
  July 16, 2025
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

